10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionFred Alger Management, Llc
Latest Disclosed Ownership111,879 shares
Latest Disclosed Value $ 2,375,191
Fred Alger Management, Llc reports 10.03% increase in ownership of TXG / 10x Genomics, Inc.

On May 15, 2026 - Fred Alger Management, Llc filed a 13F-HR form disclosing ownership of 111,879 shares of 10x Genomics, Inc. (MX:TXG) valued at $2,375,191 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 101,683 shares of 10x Genomics, Inc.. This represents a change in shares of 10.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F 10x Genomics Inc Equity 88025U109 111,879 10,196 10.03 2,375 43.24 0.0066
2026-02-17 2025-12-31 13F 10x Genomics Inc Equity 88025U109 101,683 36,300 55.52 1,658 117.02 0.0065
2025-11-14 2025-09-30 13F 10x Genomics Inc Equity 88025U109 65,383 -78,030 -54.41 764 -53.98 0.0030
2025-08-14 2025-06-30 13F 10x Genomics Inc Equity 88025U109 143,413 77,983 119.19 1,661 190.72 0.0074
2025-05-16 2025-03-31 13F 10x Genomics Inc Equity 88025U109 65,430 0 0.00 571 -39.19 0.0033
2025-02-14 2024-12-31 13F 10x Genomics Inc Equity 88025U109 65,430 -42 -0.06 940 -36.47 0.0045
2024-11-14 2024-09-30 13F 10X GENOMICS Common 88025U109 65,472 -501 -0.76 1,478 15.20 0.0072
2024-08-14 2024-06-30 13F 10X GENOMICS Common 88025U109 65,973 -379,594 -85.19 1,283 -92.33 0.0062
2024-05-15 2024-03-31 13F 10X GENOMICS Common 88025U109 445,567 40,384 9.97 16,722 -26.25 0.0829
2024-02-14 2023-12-31 13F 10X GENOMICS Common 88025U109 405,183 405,183 22,674 0.1223
2023-08-14 2023-06-30 13F 10X GENOMICS Common 88025U109 0 -8,820 -100.00 0 -100.00
2023-05-16 2023-03-31 13F/A-1 10X GENOMICS Common 88025U109 8,820 8,820 492 0.0026
2023-05-15 2023-03-31 13F 10X GENOMICS Common 88025U109 8,820 8,820 492 0.0024
2022-08-15 2022-06-30 13F 10X GENOMICS Common 88025U109 0 -328,561 -100.00 0 -100.00
2022-05-16 2022-03-31 13F 10X GENOMICS Common 88025U109 328,561 248,537 310.58 24,994 109.68 0.0798
2022-02-14 2021-12-31 13F 10X GENOMICS Common 88025U109 80,024 -76,023 -48.72 11,920 -47.53 0.0299
2021-11-15 2021-09-30 13F 10X GENOMICS Common 88025U109 156,047 16,610 11.91 22,717 -16.80 0.0542
2021-08-16 2021-06-30 13F 10X GENOMICS Common 88025U109 139,437 -27,875 -16.66 27,305 -9.83 0.0644
2021-05-17 2021-03-31 13F 10X GENOMICS Common 88025U109 167,312 106,728 176.17 30,283 252.99 0.0792
2021-02-16 2020-12-31 13F 10X GENOMICS Common 88025U109 60,584 27,046 80.64 8,579 105.14 0.0223
2020-11-13 2020-09-30 13F 10X GENOMICS Common 88025U109 33,538 9,123 37.37 4,182 91.75 0.0121
2020-08-14 2020-06-30 13F 10X GENOMICS Common 88025U109 24,415 -12,002 -32.96 2,181 -3.92 0.0072
2020-05-19 2020-03-31 13F/A-1 10X GENOMICS Common 88025U109 36,417 1,714 4.94 2,270 -14.21 0.0100
2020-05-15 2020-03-31 13F 10X GENOMICS Common 88025U109 36,417 1,714 2,270 9,987.4444
2020-02-14 2019-12-31 13F 10X GENOMICS Common 88025U109 34,703 28,703 478.38 2,646 776.16 0.0097
2019-11-14 2019-09-30 13F 10X GENOMICS Common 88025U109 6,000 6,000 302 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.